v3.24.3
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
Stock option activity during the nine months ended September 30, 2024, was as follows (in thousands, except per share amounts):
Stock Options Outstanding
SharesWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term
Aggregate Intrinsic
Value (1)
(in years)
Outstanding as of December 31, 202313,043$15.41 6.1$282,197 
Exercised
(2,220)9.13 
Forfeited (10)2.96 
Outstanding as of September 30, 202410,813$16.71 6.2$169,383 
Exercisable as of September 30, 20246,537$14.58 5.2$116,310 
(1)We calculate intrinsic value based on the difference between the exercise price of in-the-money-stock options and the fair value of our common stock as of the respective balance sheet date.
Schedule of Restricted Stock Unit Activity
RSU and RSA activity during the nine months ended September 30, 2024, was as follows (in thousands, except per share amounts):
Restricted Stock Units and Restricted Stock Awards Outstanding
SharesWeighted Average Grant Date Fair Value
Outstanding as of December 31, 202345,099$25.83 
Granted
20,08034.79 
Released(19,514)28.22 
Forfeited
(4,295)26.93 
Outstanding as of September 30, 202441,370$28.93 
Schedule of Share-Based Compensation Expense
Share-based compensation expense during the three and nine months ended September 30, 2024 and 2023, was as follows (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Cost of revenue
$3,943 $2,989 $10,668 $8,038 
Research and development138,610 112,879 369,446 315,724 
Sales and marketing32,389 25,857 88,284 71,444 
General and administrative
33,034 30,156 98,484 89,427 
Total share-based compensation
$207,976 $171,881 $566,882 $484,633